These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9449944)

  • 1. Acyclic nucleoside phosphonates: a new dimension to the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    J Med Microbiol; 1998 Jan; 47(1):1-3. PubMed ID: 9449944
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
    J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stealth nucleosides: mode of action and potential use in the treatment of viral diseases.
    Daifuku R
    BioDrugs; 2003; 17(3):169-77. PubMed ID: 12749753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E; Holý A
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral acyclic nucleoside phosphonates structure activity studies.
    Holý A
    Antiviral Res; 2006 Sep; 71(2-3):248-53. PubMed ID: 16857275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for antiviral chemotherapy.
    Stuart-Harris C
    J Antimicrob Chemother; 1975 Jun; 1(2):133-5. PubMed ID: 1165227
    [No Abstract]   [Full Text] [Related]  

  • 7. The Holý Trinity: the acyclic nucleoside phosphonates.
    De Clercq E
    Adv Pharmacol; 2013; 67():293-316. PubMed ID: 23886004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drug discovery and development: where chemistry meets with biomedicine.
    De Clercq E
    Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.
    Hocková D; Holý A; Masojídková M; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 2003 Nov; 46(23):5064-73. PubMed ID: 14584956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unachieved antiviral strategies with acyclic nucleoside phosphonates: Dedicated to the memory of dr. Salvatore "Sam" Joseph Enna.
    De Clercq E; Li G; Zhang Y; Huang J; Tan L
    Biochem Pharmacol; 2024 Oct; 228():116448. PubMed ID: 39043335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends and development in antiviral chemotherapy.
    De Clercq E
    Antiviral Res; 1985; Suppl 1():11-9. PubMed ID: 2417547
    [No Abstract]   [Full Text] [Related]  

  • 12. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
    De Clercq E
    Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducers of interferon and host resistance. VI. Antiviral efficacy of poly I:C in animal models.
    Nemes MM; Tytell AA; Lampson GP; Field AK; Hilleman MR
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):776-83. PubMed ID: 5355140
    [No Abstract]   [Full Text] [Related]  

  • 15. [Status and prospects of the chemotherapy of viral infections].
    Pershin GN
    Farmakol Toksikol; 1975; 38(5):517-27. PubMed ID: 1183580
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic potential of phosphonylmethoxyalkylpurines and -pyrimidines as antiviral agents.
    De Clercq E
    Drugs Exp Clin Res; 1990; 16(7):319-26. PubMed ID: 1965499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.
    Naesens L; Balzarini J; De Clercq E
    Postepy Biochem; 1995; 41(5 Suppl):347-51. PubMed ID: 8797236
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of 3'-azido-2',3'-dideoxythymidine on experimental viral infections].
    Shneĭder MA; Rudenko NK; Kavsan VM; Bibilashvili RSh; Kraevskiĭ AA
    Mol Biol (Mosk); 1987; 21(3):837-46. PubMed ID: 2821379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
    Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
    Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in antiviral nucleoside and nucleotide therapeutics.
    Simons C; Wu Q; Htar TT
    Curr Top Med Chem; 2005; 5(13):1191-203. PubMed ID: 16305526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.